STAGE 0A BLADDER CANCER AJCC V8

This early-stage trial is testing a new targeted treatment for bladder cancer that has returned or hasn't responded to standard therapy. Researchers are using microscopic particles designed to deliver cancer-killing medication directly to tumor cells in the bladder. The study wil…

This large, late-stage trial is testing if adding a chemotherapy drug called gemcitabine to the standard BCG treatment is more effective at controlling recurrent, high-grade bladder cancer that hasn't invaded the muscle wall. The study will compare the combination treatment again…

This study is testing whether a common bladder cancer treatment can be safely and effectively given at home instead of requiring frequent clinic visits. It will involve about 40 patients with early-stage bladder cancer who are already receiving standard liquid chemotherapy placed…

This early-stage study is testing whether a new vaccine (IO102-IO103) combined with an existing immunotherapy drug (pembrolizumab) is safe and effective for patients with high-risk bladder cancer that hasn't responded to standard BCG treatment. The vaccine is designed to teach th…

This study is testing whether a healthy eating program focused on vegetables like broccoli, cabbage, and kale can help prevent early-stage bladder cancer from coming back or getting worse. Researchers are enrolling 344 adults in New York who have had this type of cancer to compar…

This study is testing whether a personalized home exercise program delivered through a smartphone app can help people with early-stage bladder cancer become more physically active. Researchers will compare the app, which provides exercise videos and step goals, to a group that on…

This study aims to understand how different treatments for early-stage bladder cancer affect patients' quality of life over time. Researchers will follow 704 survivors for three years, asking them to complete surveys about their physical, emotional, and social well-being. The goa…